Please enable JavaScript to continue using this application.

Compare $CRL vs $RVTY | Chartloom

Compare

$CRL vs $RVTY

Charles River Laboratories International Inc · Revvity Inc

CRL

Charles River Laboratories International Inc

RVTY

Revvity Inc

Compare $CRL vs $RVTY

Comparing Charles River Laboratories International Inc and Revvity Inc

CRLCharles River Laboratories International Inc

RVTYRevvity Inc

CRLCharles River Laboratories International Inc

Market cap

$14.54B

P/E (TTM)

—

Forward P/E (NTM)

24.21x

Forward P/S (NTM)

3.68x

Rev growth (TTM)

-0.7%

YTD performance

49.1%

52W performance

74.0%

FCF yield

2.5%

RVTYRevvity Inc

Market cap

$17.20B

P/E (TTM)

72.45x

Forward P/E (NTM)

26.16x

Forward P/S (NTM)

5.62x

Rev growth (TTM)

4.1%

YTD performance

57.1%

52W performance

68.0%

FCF yield

3.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRL

RVTY

Detailed metrics comparison

CRL

Charles River Laboratories International Inc

RVTY

Revvity Inc

Market Cap

CRL$14.54B

RVTY$17.20B

Enterprise Value

CRL$16.97B

RVTY$19.38B

Price

CRL$301.79

RVTY$154.18

P/E Ratio

CRLN/A

RVTY72.45x

P/S Ratio

CRL3.64x

RVTY5.91x

EV/Sales

CRL4.24x

RVTY6.66x

EV/EBITDA

CRL19.41x

RVTY23.79x

P/B Ratio

CRL4.88x

RVTY2.34x

P/FCF Ratio

CRL39.23x

RVTY30.82x

EV/FCF

CRL45.79x

RVTY34.73x

PEG Ratio

CRLN/A

RVTY7.30x

Forward P/E (NTM)

CRL24.21x

RVTY26.16x

Forward P/S (NTM)

CRL3.68x

RVTY5.62x

Revenue (TTM)

CRL$4.00B

RVTY$2.91B

Revenue Growth (YoY)

CRL-0.7%

RVTY4.1%

Forward Rev Growth

CRL2.3%

RVTY5.2%

Gross Margin (TTM)

CRL34.6%

RVTY55.0%

Operating Margin (TTM)

CRL2.3%

RVTY12.3%

EBITDA Margin (TTM)

CRL21.6%

RVTY28.0%

Net Margin (TTM)

CRL-6.0%

RVTY8.2%

FCF Margin (TTM)

CRL9.3%

RVTY19.2%

Net Income (TTM)

CRL$-238M

RVTY$238M

FCF (TTM)

CRL$371M

RVTY$558M

EPS (TTM)

CRL-$4.97

RVTY$2.13

ROE (TTM)

CRL-772.0%

RVTY3.3%

ROA (TTM)

CRL-319.0%

RVTY2.0%

ROIC (TTM)

CRL-434.0%

RVTY2.3%

Cash

CRL$192M

RVTY$1.02B

Debt

CRL$2.63B

RVTY$3.21B

Net Cash/Debt

CRL$-2.43B

RVTY$-2.18B

Current Ratio (TTM)

CRL1.35x

RVTY1.80x

Quick Ratio (TTM)

CRL0.83x

RVTY1.50x

Debt/Equity (TTM)

CRL0.93x

RVTY0.44x

Debt/Assets (TTM)

CRL0.0%

RVTY0.0%

Interest Coverage (TTM)

CRLN/A

RVTYN/A

Net Debt/EBITDA (TTM)

CRL0.00x

RVTY0.00x

Beta

CRL1.38

RVTY1.09

52W Performance

CRL74.0%

RVTY68.0%

YTD Performance

CRL49.1%

RVTY57.1%

% from 52W High

CRL-9.5%

RVTY-7.3%

% from 52W Low

CRL106.4%

RVTY89.8%

Asset Turnover (TTM)

CRL0.53x

RVTY0.24x

FCF Yield (TTM)

CRL2.5%

RVTY3.2%

Earnings Yield (TTM)

CRL-1.6%

RVTY1.4%

Dividend Yield (TTM)

CRLN/A

RVTY0.2%

Rule of 40

CRL8.5

RVTY23.2

EV/GP/RG

CRL5.20

RVTY2.33

Ticker research

View CRL research View RVTY research

Metric	CRL Charles River Laboratories International Inc	RVTY Revvity Inc
Market & Valuation
Market Cap	$14.54B	$17.20B
Enterprise Value	$16.97B	$19.38B
Price	$301.79	$154.18
P/E Ratio	N/A	72.45x
P/S Ratio	3.64x	5.91x
EV/Sales	4.24x	6.66x
EV/EBITDA	19.41x	23.79x
P/B Ratio	4.88x	2.34x
P/FCF Ratio	39.23x	30.82x
EV/FCF	45.79x	34.73x
PEG Ratio	N/A	7.30x
Forward P/E (NTM)	24.21x	26.16x
Forward P/S (NTM)	3.68x	5.62x
Revenue & Growth
Revenue (TTM)	$4.00B	$2.91B
Revenue Growth (YoY)	-0.7%	4.1%
Forward Rev Growth	2.3%	5.2%
Profitability
Gross Margin (TTM)	34.6%	55.0%
Operating Margin (TTM)	2.3%	12.3%
EBITDA Margin (TTM)	21.6%	28.0%
Net Margin (TTM)	-6.0%	8.2%
FCF Margin (TTM)	9.3%	19.2%
Net Income (TTM)	$-238M	$238M
FCF (TTM)	$371M	$558M
EPS (TTM)	-$4.97	$2.13
ROE (TTM)	-772.0%	3.3%
ROA (TTM)	-319.0%	2.0%
ROIC (TTM)	-434.0%	2.3%
Financial Health
Cash	$192M	$1.02B
Debt	$2.63B	$3.21B
Net Cash/Debt	$-2.43B	$-2.18B
Current Ratio (TTM)	1.35x	1.80x
Quick Ratio (TTM)	0.83x	1.50x
Debt/Equity (TTM)	0.93x	0.44x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.38	1.09
52W Performance	74.0%	68.0%
YTD Performance	49.1%	57.1%
% from 52W High	-9.5%	-7.3%
% from 52W Low	106.4%	89.8%
Efficiency & Yields
Asset Turnover (TTM)	0.53x	0.24x
FCF Yield (TTM)	2.5%	3.2%
Earnings Yield (TTM)	-1.6%	1.4%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	8.5	23.2
EV/GP/RG	5.20	2.33
Ticker research	View CRL research	View RVTY research

Valuation

P/E Ratio

RVTY

72.45x

P/S Ratio

CRL

3.64x

RVTY

5.91x

EV/FCF

RVTY

34.73x

CRL

45.79x

Growth & revenue

Revenue Growth TTM

RVTY

4.1%

CRL

-0.7%

Forward Revenue Growth

RVTY

5.2%

CRL

2.3%

Profitability & performance

Gross Margin

RVTY

55.0%

CRL

34.6%

ROE

RVTY

3.3%

CRL

-772.0%

FCF Yield %

RVTY

3.2%

CRL

2.5%

52-Week Performance

CRL

74.0%

RVTY

68.0%

Detailed metrics comparison

CRL

Charles River Laboratories International Inc

RVTY

Revvity Inc

Market Cap

CRL$14.54B

RVTY$17.20B

Enterprise Value

CRL$16.97B

RVTY$19.38B

Price

CRL$301.79

RVTY$154.18

P/E Ratio

CRLN/A

RVTY72.45x

P/S Ratio

CRL3.64x

RVTY5.91x

EV/Sales

CRL4.24x

RVTY6.66x

EV/EBITDA

CRL19.41x

RVTY23.79x

P/B Ratio

CRL4.88x

RVTY2.34x

P/FCF Ratio

CRL39.23x

RVTY30.82x

EV/FCF

CRL45.79x

RVTY34.73x

PEG Ratio

CRLN/A

RVTY7.30x

Forward P/E (NTM)

CRL24.21x

RVTY26.16x

Forward P/S (NTM)

CRL3.68x

RVTY5.62x

Revenue (TTM)

CRL$4.00B

RVTY$2.91B

Revenue Growth (YoY)

CRL-0.7%

RVTY4.1%

Forward Rev Growth

CRL2.3%

RVTY5.2%

Gross Margin (TTM)

CRL34.6%

RVTY55.0%

Operating Margin (TTM)

CRL2.3%

RVTY12.3%

EBITDA Margin (TTM)

CRL21.6%

RVTY28.0%

Net Margin (TTM)

CRL-6.0%

RVTY8.2%

FCF Margin (TTM)

CRL9.3%

RVTY19.2%

Net Income (TTM)

CRL$-238M

RVTY$238M

FCF (TTM)

CRL$371M

RVTY$558M

EPS (TTM)

CRL-$4.97

RVTY$2.13

ROE (TTM)

CRL-772.0%

RVTY3.3%

ROA (TTM)

CRL-319.0%

RVTY2.0%

ROIC (TTM)

CRL-434.0%

RVTY2.3%

Cash

CRL$192M

RVTY$1.02B

Debt

CRL$2.63B

RVTY$3.21B

Net Cash/Debt

CRL$-2.43B

RVTY$-2.18B

Current Ratio (TTM)

CRL1.35x

RVTY1.80x

Quick Ratio (TTM)

CRL0.83x

RVTY1.50x

Debt/Equity (TTM)

CRL0.93x

RVTY0.44x

Debt/Assets (TTM)

CRL0.0%

RVTY0.0%

Interest Coverage (TTM)

CRLN/A

RVTYN/A

Net Debt/EBITDA (TTM)

CRL0.00x

RVTY0.00x

Beta

CRL1.38

RVTY1.09

52W Performance

CRL74.0%

RVTY68.0%

YTD Performance

CRL49.1%

RVTY57.1%

% from 52W High

CRL-9.5%

RVTY-7.3%

% from 52W Low

CRL106.4%

RVTY89.8%

Asset Turnover (TTM)

CRL0.53x

RVTY0.24x

FCF Yield (TTM)

CRL2.5%

RVTY3.2%

Earnings Yield (TTM)

CRL-1.6%

RVTY1.4%

Dividend Yield (TTM)

CRLN/A

RVTY0.2%

Rule of 40

CRL8.5

RVTY23.2

EV/GP/RG

CRL5.20

RVTY2.33

Ticker research

View CRL research View RVTY research

Metric	CRL Charles River Laboratories International Inc	RVTY Revvity Inc
Market & Valuation
Market Cap	$14.54B	$17.20B
Enterprise Value	$16.97B	$19.38B
Price	$301.79	$154.18
P/E Ratio	N/A	72.45x
P/S Ratio	3.64x	5.91x
EV/Sales	4.24x	6.66x
EV/EBITDA	19.41x	23.79x
P/B Ratio	4.88x	2.34x
P/FCF Ratio	39.23x	30.82x
EV/FCF	45.79x	34.73x
PEG Ratio	N/A	7.30x
Forward P/E (NTM)	24.21x	26.16x
Forward P/S (NTM)	3.68x	5.62x
Revenue & Growth
Revenue (TTM)	$4.00B	$2.91B
Revenue Growth (YoY)	-0.7%	4.1%
Forward Rev Growth	2.3%	5.2%
Profitability
Gross Margin (TTM)	34.6%	55.0%
Operating Margin (TTM)	2.3%	12.3%
EBITDA Margin (TTM)	21.6%	28.0%
Net Margin (TTM)	-6.0%	8.2%
FCF Margin (TTM)	9.3%	19.2%
Net Income (TTM)	$-238M	$238M
FCF (TTM)	$371M	$558M
EPS (TTM)	-$4.97	$2.13
ROE (TTM)	-772.0%	3.3%
ROA (TTM)	-319.0%	2.0%
ROIC (TTM)	-434.0%	2.3%
Financial Health
Cash	$192M	$1.02B
Debt	$2.63B	$3.21B
Net Cash/Debt	$-2.43B	$-2.18B
Current Ratio (TTM)	1.35x	1.80x
Quick Ratio (TTM)	0.83x	1.50x
Debt/Equity (TTM)	0.93x	0.44x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.38	1.09
52W Performance	74.0%	68.0%
YTD Performance	49.1%	57.1%
% from 52W High	-9.5%	-7.3%
% from 52W Low	106.4%	89.8%
Efficiency & Yields
Asset Turnover (TTM)	0.53x	0.24x
FCF Yield (TTM)	2.5%	3.2%
Earnings Yield (TTM)	-1.6%	1.4%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	8.5	23.2
EV/GP/RG	5.20	2.33
Ticker research	View CRL research	View RVTY research